NCT03753659 2026-03-23
IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2 Completed
Clinical Trials
6 trialsNCT02437071 2025-12-05
Assess the Efficacy of Pembrolizumab Plus Radiotherapy or Ablation in Metastatic Colorectal Cancer Patients
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT02558504 2025-10-02
HARMONI
Hospices Civils de Lyon
Phase 4 Completed
NCT02163525 2025-09-30
Post Market TRUST - U.S.A. Study
Acessa Health, Inc.
Phase NA Completed
NCT04389216 2025-09-15
RFA
Hospital Universitari de Bellvitge
Phase NA Completed
NCT00712712 2025-08-29
MEDOR
Institut Bergonié
Phase 2 Completed